Fresenius Medical Care Ag ADR (FMS)

$23.37 -0.20 (-0.85%)
Market Cap 13.93B
Revenue (ttm) 20.92B
Net Income (ttm) 582.08M
EPS (ttm) N/A
PE Ratio 11.41
Forward PE 10.69
Profit Margin 2.78%
Debt to Equity Ratio 0.49
Volume 950,932
Avg Vol 414,680
Day's Range N/A - N/A
Shares Out 586.83M
Stochastic %K 35%
Beta 0.89
Analysts Sell
Price Target $27.74

Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract...

Industry: Medical Care Facilities
Sector: Healthcare
Phone: 49 6172 609 0
Address:
Else-Kröner-Strasse 1, Bad Homburg, Germany
Noname2022
Noname2022 Dec. 4 at 4:01 AM
$CRMD $FMS
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 3 at 6:59 PM
$FMS Current Stock Price: $23.61 Contracts to trade: $20 FMS Jan 16 2026 Call Entry: $4.90 Exit: $6.42 ROI: 31% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
jpstrings
jpstrings Dec. 3 at 11:03 AM
$POET $AKBA $CRMD $FMS @Stocktwits ban this lowlife scammer
0 · Reply
Noname2022
Noname2022 Dec. 3 at 1:05 AM
$CRMD $FMS https://www.tiktok.com/@akidneylife/video/7542930015248223519
1 · Reply
Noname2022
Noname2022 Dec. 1 at 11:50 PM
If your following the dialysis space… Buy $CRMD & $FMS Sell $AKBA & $DVA Men lie. Women lie. Numbers don’t.
2 · Reply
Noname2022
Noname2022 Nov. 29 at 1:46 PM
$CRMD $FMS $DVA $ICUI
1 · Reply
Noname2022
Noname2022 Nov. 29 at 1:26 PM
$CRMD $DVA $FMS $ICUI Clearguard HD caps used in 40 Fresenius facilities https://www.ajkd.org/article/s0272-6386%2816%2930519-4/
1 · Reply
Noname2022
Noname2022 Nov. 29 at 1:18 PM
$CRMD $ICUI $DVA $FMS Impact of using Clearguard HD caps at HCA inpatient (largest private hospital) https://2024apic.eventscribe.net/fsPopup.asp?PosterID=668778&mode=posterInfo
1 · Reply
Noname2022
Noname2022 Nov. 29 at 12:27 PM
$CRMD $DVA $FMS Overall infections are down for all dialysis facilities from 2018 to 2022
1 · Reply
Noname2022
Noname2022 Nov. 29 at 11:48 AM
$CRMD $FMS $DVA Worldwide 12% of deaths and 5% of hospitalizations are due to infections in dialysis patients
1 · Reply
Latest News on FMS
Fresenius Medical Care: 'Buy' Again Following A Peak In May

Nov 25, 2025, 10:50 AM EST - 9 days ago

Fresenius Medical Care: 'Buy' Again Following A Peak In May

Fresenius Medical Care AG (FMS) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 4:26 PM EST - 4 weeks ago

Fresenius Medical Care AG (FMS) Q3 2025 Earnings Call Transcript

Fresenius Medical Care further accelerates organic revenue development and achieves an inflection in earnings growth, delivering 28% operating income growth in the third quarter of 2025

Nov 4, 2025, 7:00 AM EST - 4 weeks ago

Fresenius Medical Care further accelerates organic revenue development and achieves an inflection in earnings growth, delivering 28% operating income growth in the third quarter of 2025

Fresenius Medical Care beats quarterly profit estimates helped by cost cuts

Nov 4, 2025, 1:08 AM EST - 4 weeks ago

Fresenius Medical Care beats quarterly profit estimates helped by cost cuts

Fresenius Medical Care highlights real-world advances in hemodiafiltration and AI at ASN Kidney Week 2025

Oct 30, 2025, 9:00 AM EDT - 5 weeks ago

Fresenius Medical Care highlights real-world advances in hemodiafiltration and AI at ASN Kidney Week 2025

Fresenius Medical Care appoints Joseph Turk as new Management Board Member for Care Enablement

Oct 1, 2025, 9:35 AM EDT - 2 months ago

Fresenius Medical Care appoints Joseph Turk as new Management Board Member for Care Enablement

Fresenius Medical Care advances its FME Reignite strategy by increasing ownership in its Value-Based Care asset and appointing a new leader for the operating segment

Sep 18, 2025, 3:30 PM EDT - 2 months ago

Fresenius Medical Care advances its FME Reignite strategy by increasing ownership in its Value-Based Care asset and appointing a new leader for the operating segment

Fresenius Medical Care announces first tranche of its share buyback program of up to EUR 600 million as part of its new capital allocation framework

Aug 11, 2025, 7:00 AM EDT - 4 months ago

Fresenius Medical Care announces first tranche of its share buyback program of up to EUR 600 million as part of its new capital allocation framework

Fresenius Medical Care AG (FMS) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 11:23 AM EDT - 4 months ago

Fresenius Medical Care AG (FMS) Q2 2025 Earnings Call Transcript

Fresenius Medical Care delivers strong organic revenue growth and double-digit operating income growth in the second quarter of 2025

Aug 5, 2025, 7:00 AM EDT - 4 months ago

Fresenius Medical Care delivers strong organic revenue growth and double-digit operating income growth in the second quarter of 2025

Fresenius Medical Care: Is Trading Below Its Intrinsic Value (Buy)

Jul 22, 2025, 7:31 AM EDT - 4 months ago

Fresenius Medical Care: Is Trading Below Its Intrinsic Value (Buy)

$6.3 Trillion Outpatient Clinics Markets, 2021-2024 & 2025-2029 | Profiles of Leading Players - Johns Hopkins Medicine, Mayo Clinic, MD Anderson Cancer Center, Apollo Hospital, and Fresenius Medical

Jul 18, 2025, 4:25 AM EDT - 4 months ago

$6.3 Trillion Outpatient Clinics Markets, 2021-2024 & 2025-2029 | Profiles of Leading Players - Johns Hopkins Medicine, Mayo Clinic, MD Anderson Cancer Center, Apollo Hospital, and Fresenius Medical

Fresenius Medical Care Collaborates with Coordination of National Institutes of Health and Specialty Hospital to Extend Access to Innovative Dialysis Therapy in Mexico

Jul 3, 2025, 8:00 AM EDT - 5 months ago

Fresenius Medical Care Collaborates with Coordination of National Institutes of Health and Specialty Hospital to Extend Access to Innovative Dialysis Therapy in Mexico

Fresenius Medical Care Launches Value-Based Care Segment, Eyes Growth Through Innovation, Efficiency

Jun 17, 2025, 1:21 PM EDT - 6 months ago

Fresenius Medical Care Launches Value-Based Care Segment, Eyes Growth Through Innovation, Efficiency

Fresenius Medical Care CEO Says Company Could Benefit From Obesity Drugs

Jun 17, 2025, 8:56 AM EDT - 6 months ago

Fresenius Medical Care CEO Says Company Could Benefit From Obesity Drugs

Fresenius Medical Care Launches its Strategy FME Reignite with increased Profitability Aspirations, and a New Capital Allocation Framework to further enhance Value Creation

Jun 17, 2025, 7:00 AM EDT - 6 months ago

Fresenius Medical Care Launches its Strategy FME Reignite with increased Profitability Aspirations, and a New Capital Allocation Framework to further enhance Value Creation

Fresenius Medical Care announces 1 bln euros share buyback programme

Jun 17, 2025, 4:08 AM EDT - 6 months ago

Fresenius Medical Care announces 1 bln euros share buyback programme

5 Stocks To Ride The German Market Rally

Jun 16, 2025, 3:06 PM EDT - 6 months ago

5 Stocks To Ride The German Market Rally

BNTX SAP

Fresenius Medical Care Begins Broader U.S. Commercialization of 5008X™ CAREsystem, Achieves Key Milestones in Efforts to Introduce High-Volume Hemodiafiltration Dialysis Therapy to Individuals with Kidney Disease in the U.S.

Jun 4, 2025, 8:00 AM EDT - 6 months ago

Fresenius Medical Care Begins Broader U.S. Commercialization of 5008X™ CAREsystem, Achieves Key Milestones in Efforts to Introduce High-Volume Hemodiafiltration Dialysis Therapy to Individuals with Kidney Disease in the U.S.

Fresenius Medical Care presents its new research and innovation for kidney care at European Renal Association Congress 2025

May 30, 2025, 8:00 AM EDT - 6 months ago

Fresenius Medical Care presents its new research and innovation for kidney care at European Renal Association Congress 2025

Fresenius Medical Care Annual General Meeting: Strong Performance Against Its Strategic Plan Results in Highest Dividend per Share in Its History

May 22, 2025, 11:45 AM EDT - 7 months ago

Fresenius Medical Care Annual General Meeting: Strong Performance Against Its Strategic Plan Results in Highest Dividend per Share in Its History

Fresenius Medical Care AG (FMS) Q1 2025 Earnings Conference Call Transcript

May 8, 2025, 3:08 AM EDT - 7 months ago

Fresenius Medical Care AG (FMS) Q1 2025 Earnings Conference Call Transcript

Fresenius Medical Care starts 2025 with strong organic revenue and income growth

May 6, 2025, 7:00 AM EDT - 7 months ago

Fresenius Medical Care starts 2025 with strong organic revenue and income growth

Fresenius Medical Care tops market expectations in 1st quarter

May 6, 2025, 1:04 AM EDT - 7 months ago

Fresenius Medical Care tops market expectations in 1st quarter

BMO's Siegerman talks the impact of tariffs on pharmaceutical stocks

Apr 9, 2025, 6:32 PM EDT - 8 months ago

BMO's Siegerman talks the impact of tariffs on pharmaceutical stocks

ABBV AMGN AZN BMY GSK JNJ LLY

Fresenius Medical Care publishes its joint Annual Report and Sustainability Statement for 2024: Building the Momentum

Mar 13, 2025, 8:00 AM EDT - 9 months ago

Fresenius Medical Care publishes its joint Annual Report and Sustainability Statement for 2024: Building the Momentum

Fresenius Medical Care's stock falls on Fresenius' stake sale

Mar 4, 2025, 3:57 AM EST - 9 months ago

Fresenius Medical Care's stock falls on Fresenius' stake sale

Fresenius Medical Care AG (FMS) Q4 2024 Earnings Conference Call Transcript

Feb 25, 2025, 2:59 PM EST - 10 months ago

Fresenius Medical Care AG (FMS) Q4 2024 Earnings Conference Call Transcript

Fresenius Medical Care delivers 18% earnings growth in 2024 and continues the acceleration momentum into 2025

Feb 25, 2025, 7:00 AM EST - 10 months ago

Fresenius Medical Care delivers 18% earnings growth in 2024 and continues the acceleration momentum into 2025

Fresenius Medical Care slightly beats market estimates in fourth quarter

Feb 25, 2025, 1:14 AM EST - 10 months ago

Fresenius Medical Care slightly beats market estimates in fourth quarter

Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics

Feb 24, 2025, 8:00 AM EST - 10 months ago

Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics

DGX

Fresenius Medical Care: A 'Buy' Going Into 2025

Jan 31, 2025, 6:20 AM EST - 10 months ago

Fresenius Medical Care: A 'Buy' Going Into 2025

Fresenius Medical Care Listed in The Dow Jones Sustainability World Index and for the 15th Time in The Dow Jones Sustainability Europe Index

Dec 23, 2024, 9:00 AM EST - 1 year ago

Fresenius Medical Care Listed in The Dow Jones Sustainability World Index and for the 15th Time in The Dow Jones Sustainability Europe Index

Fresenius Medical Care returns to Dax 40 Index

Dec 20, 2024, 11:23 AM EST - 1 year ago

Fresenius Medical Care returns to Dax 40 Index

Hard work paying off despite challenges from U.S. weather-related events: Fresenius Medical Care CEO

Nov 5, 2024, 8:33 PM EST - 1 year ago

Hard work paying off despite challenges from U.S. weather-related events: Fresenius Medical Care CEO

Fresenius Medical Care AG (FMS) Q3 2024 Earnings Call Transcript

Nov 5, 2024, 2:34 PM EST - 1 year ago

Fresenius Medical Care AG (FMS) Q3 2024 Earnings Call Transcript

Fresenius Medical Care reports strong operating income margin growth in the third quarter of 2024

Nov 5, 2024, 7:00 AM EST - 1 year ago

Fresenius Medical Care reports strong operating income margin growth in the third quarter of 2024

Fresenius Medical Care Showcases Research and Innovations in Kidney Care at American Society of Nephrology (ASN) Kidney Week 2024

Oct 21, 2024, 11:04 AM EDT - 1 year ago

Fresenius Medical Care Showcases Research and Innovations in Kidney Care at American Society of Nephrology (ASN) Kidney Week 2024

Fresenius Medical Care: Let's Look At The Upside

Oct 4, 2024, 4:04 PM EDT - 1 year ago

Fresenius Medical Care: Let's Look At The Upside

Fresenius Medical Care Grows Number of U.S. Patients Using Company's Home Hemodialysis Machines, Launches NxStage® Versi®HD with GuideMe Software

Sep 4, 2024, 8:00 AM EDT - 1 year ago

Fresenius Medical Care Grows Number of U.S. Patients Using Company's Home Hemodialysis Machines, Launches NxStage® Versi®HD with GuideMe Software

Fresenius Medical Care CEO says strategy is working as company delivers on transformation efforts

Jul 30, 2024, 9:30 PM EDT - 1 year ago

Fresenius Medical Care CEO says strategy is working as company delivers on transformation efforts

Fresenius Medical Care AG (FMS) Q2 2024 Earnings Call Transcript

Jul 30, 2024, 12:39 PM EDT - 1 year ago

Fresenius Medical Care AG (FMS) Q2 2024 Earnings Call Transcript

Fresenius Medical Care delivers continued operating income improvements in the second quarter of 2024

Jul 30, 2024, 7:00 AM EDT - 1 year ago

Fresenius Medical Care delivers continued operating income improvements in the second quarter of 2024

US FTC probing DaVita, Fresenius Medical, Politico reports

Jul 13, 2024, 9:16 AM EDT - 1 year ago

US FTC probing DaVita, Fresenius Medical, Politico reports

DVA

Fresenius Medical Care: Significant Upside Remains

Jun 25, 2024, 6:15 AM EDT - 1 year ago

Fresenius Medical Care: Significant Upside Remains

Fresenius Medical Care takes next important step towards goal to reduce CO2 emissions in its operations

Jun 12, 2024, 8:00 AM EDT - 1 year ago

Fresenius Medical Care takes next important step towards goal to reduce CO2 emissions in its operations

Moody's and S&P change Fresenius Medical Care's rating outlook to stable

May 23, 2024, 12:33 PM EDT - 1 year ago

Moody's and S&P change Fresenius Medical Care's rating outlook to stable

Fresenius Medical Care showcases leadership and innovation in kidney care disease at 61st European Renal Association (ERA) Congress 2024

May 21, 2024, 10:00 AM EDT - 1 year ago

Fresenius Medical Care showcases leadership and innovation in kidney care disease at 61st European Renal Association (ERA) Congress 2024

Fresenius Medical Care Annual General Meeting: Company makes significant progress in its Transformation Efforts and confirms its ambitious 2024 Growth Targets

May 16, 2024, 9:55 AM EDT - 1 year ago

Fresenius Medical Care Annual General Meeting: Company makes significant progress in its Transformation Efforts and confirms its ambitious 2024 Growth Targets

Fresenius Medical sees up to 2% US dialysis growth by year-end

May 11, 2024, 6:42 AM EDT - 1 year ago

Fresenius Medical sees up to 2% US dialysis growth by year-end

Noname2022
Noname2022 Dec. 4 at 4:01 AM
$CRMD $FMS
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 3 at 6:59 PM
$FMS Current Stock Price: $23.61 Contracts to trade: $20 FMS Jan 16 2026 Call Entry: $4.90 Exit: $6.42 ROI: 31% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
jpstrings
jpstrings Dec. 3 at 11:03 AM
$POET $AKBA $CRMD $FMS @Stocktwits ban this lowlife scammer
0 · Reply
Noname2022
Noname2022 Dec. 3 at 1:05 AM
$CRMD $FMS https://www.tiktok.com/@akidneylife/video/7542930015248223519
1 · Reply
Noname2022
Noname2022 Dec. 1 at 11:50 PM
If your following the dialysis space… Buy $CRMD & $FMS Sell $AKBA & $DVA Men lie. Women lie. Numbers don’t.
2 · Reply
Noname2022
Noname2022 Nov. 29 at 1:46 PM
$CRMD $FMS $DVA $ICUI
1 · Reply
Noname2022
Noname2022 Nov. 29 at 1:26 PM
$CRMD $DVA $FMS $ICUI Clearguard HD caps used in 40 Fresenius facilities https://www.ajkd.org/article/s0272-6386%2816%2930519-4/
1 · Reply
Noname2022
Noname2022 Nov. 29 at 1:18 PM
$CRMD $ICUI $DVA $FMS Impact of using Clearguard HD caps at HCA inpatient (largest private hospital) https://2024apic.eventscribe.net/fsPopup.asp?PosterID=668778&mode=posterInfo
1 · Reply
Noname2022
Noname2022 Nov. 29 at 12:27 PM
$CRMD $DVA $FMS Overall infections are down for all dialysis facilities from 2018 to 2022
1 · Reply
Noname2022
Noname2022 Nov. 29 at 11:48 AM
$CRMD $FMS $DVA Worldwide 12% of deaths and 5% of hospitalizations are due to infections in dialysis patients
1 · Reply
Noname2022
Noname2022 Nov. 29 at 11:36 AM
$CRMD $DVA $FMS https://www.asn-online.org/education/kidneyweek/2025/program-abstract.aspx?controlId=4348436 Large chains have lower infections rates
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Nov. 27 at 9:48 PM
Comparing trending tickers $FMS vs $ETH: FMS is down slightly by 1% to $23.82 on a trading volume of 259,000 shares, which is below its average of 361,000 shares. In contrast, ETH is up by 3.33% to $28.55, with a significantly higher volume of 5.5 million shares compared to its average of 3.7 million. Clearly, ETH is experiencing stronger positive momentum both in terms of price increase and trading volume, while FMS is seeing a quieter day with both a drop in price and lower than usual trading activity.
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Nov. 27 at 9:19 PM
Comparing trending tickers $XOP vs $FMS: XOP is currently up by 1.12% to $131.68, trading at about half its average volume with 1.5 million shares. In contrast, FMS has dropped by 1.00% to $23.82, moving 259,000 shares, which is also below its usual volume of 361,000 shares. While both stocks are experiencing lower than average trading volumes today, XOP is seeing a bit more positive movement in its price compared to FMS.
0 · Reply
Noname2022
Noname2022 Nov. 27 at 7:31 PM
$CRMD $FMS
3 · Reply
Estimize
Estimize Nov. 26 at 11:00 AM
Wall St is expecting 0.56 EPS for $FMS Q4 [Reporting 02/24 BMO] http://www.estimize.com/intro/fms?chart=historical&metric_name=eps&utm_cont
0 · Reply
Noname2022
Noname2022 Nov. 26 at 12:39 AM
$CRMD $FMS Not new, just a reminder…
0 · Reply
Noname2022
Noname2022 Nov. 25 at 12:06 AM
$CRMD $FMS $DVA Infections are the 2nd leading cause of death in HD patients Although central venous catheters (CVC) comprise only 18.8% of HD vascular accesses they account for 69.8% of access-related BSIs (Nguyen et al, 2017) https://cormedix.com/wp-content/uploads/2019/05/LOCK-IT-100-NKF-Presentation-As-Presented-10-May-2019.pdf
1 · Reply
Noname2022
Noname2022 Nov. 23 at 10:44 PM
$CRMD $FMS https://www.ispor.org/heor-resources/presentations-database/presentation-cti/ispor-2025/poster-session-4/the-clinical-value-and-cost-effectiveness-of-defencath-for-reducing-catheter-related-bloodstream-infections-in-adult-patients-receiving-hemodialysis-through-a-central-venous-catheter
0 · Reply
AlxNT
AlxNT Nov. 23 at 10:28 PM
$CRMD $FMS
0 · Reply
Noname2022
Noname2022 Nov. 23 at 10:23 PM
$CRMD $FMS Final USRC real-world evidence expectations: Based on CMS data, 10-Q revenue math, and exposure-adjusted modeling, this is the most accurate prediction of DefenCath’s year-one effect at USRC before the RWE readout. Everything shown is derived from publicly available data and conservative assumptions.
2 · Reply
Noname2022
Noname2022 Nov. 23 at 9:26 PM
$CRMD $FMS USRC RWE – Summary
0 · Reply
Noname2022
Noname2022 Nov. 23 at 9:07 PM
$CRMD $AKBA $DVA $FMS https://ow.ly/7pBP50XuTIe
1 · Reply